Pregled bibliografske jedinice broj: 846690
Comparison of Verisyse and Veriflex Phakic intraocular lenses for treatment of moderate to high myopia 36 months after surgery
Comparison of Verisyse and Veriflex Phakic intraocular lenses for treatment of moderate to high myopia 36 months after surgery // Seminars in Ophthalmology, 32 (2017), 6; 725-733 doi:10.3109/08820538.2016.1170163 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 846690 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Comparison of Verisyse and Veriflex Phakic intraocular lenses for treatment of moderate to high myopia 36 months after surgery
Autori
Bohač, Maja ; Antičić, Marija ; Drača, Nataša ; Kozomara, Bojan ; Dekaris, Iva ; Gabrić, Nikica ; Patel, Sudi
Izvornik
Seminars in Ophthalmology (0882-0538) 32
(2017), 6;
725-733
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
endothelial cells count loss ; veriflex ; verisyse ; myopia ; phakic intraocular lenses
Sažetak
To compare refractive stability, endothelial cell count (ECC), incidence of complications, and patients' satisfaction between a rigid Verisyse (group I, n = 198) and foldable Veriflex (group II, n = 212) phakic intraocular lenses (pIOL) over 36 months postop. Both Verisyse and Veriflex pIOLs are effective in correcting myopia. The Veriflex lens demonstrated better refractive outcome ; however, subclinical inflammation observed in the Veriflex group and potential influence of inflammation on ECC loss require further investigation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Medicinski fakultet, Rijeka,
Specijalna bolnica Svjetlost
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
